GB9027197D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9027197D0
GB9027197D0 GB909027197A GB9027197A GB9027197D0 GB 9027197 D0 GB9027197 D0 GB 9027197D0 GB 909027197 A GB909027197 A GB 909027197A GB 9027197 A GB9027197 A GB 9027197A GB 9027197 D0 GB9027197 D0 GB 9027197D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909027197A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB909027197A priority Critical patent/GB9027197D0/en
Publication of GB9027197D0 publication Critical patent/GB9027197D0/en
Priority to EP92900687A priority patent/EP0561896A1/en
Priority to PCT/GB1991/002224 priority patent/WO1992010186A1/en
Priority to JP4501731A priority patent/JPH06503338A/en
Priority to AU90692/91A priority patent/AU9069291A/en
Priority to US09/794,723 priority patent/US20020055490A1/en
Priority to US10/287,955 priority patent/US20030096851A1/en
Priority to US10/404,345 priority patent/US20030187044A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB909027197A 1990-12-12 1990-12-14 Medicaments Pending GB9027197D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB909027197A GB9027197D0 (en) 1990-12-14 1990-12-14 Medicaments
EP92900687A EP0561896A1 (en) 1990-12-14 1991-12-12 Use of angiotensn ii receptor antagonists for the preparation of a medicament for improving cognitive function
PCT/GB1991/002224 WO1992010186A1 (en) 1990-12-14 1991-12-12 Use of angiotensn ii receptor antagonists for the preparation of a medicament for improving cognitive function
JP4501731A JPH06503338A (en) 1990-12-12 1991-12-12 Use of angiotensin 2 receptor antagonists in the preparation of drugs for improving cognitive function
AU90692/91A AU9069291A (en) 1990-12-14 1991-12-12 Use of angiotensin ii receptor antagonists for the preparation of a medicament for improving cognitive function
US09/794,723 US20020055490A1 (en) 1990-12-14 2001-02-27 Medicament
US10/287,955 US20030096851A1 (en) 1990-12-14 2002-11-05 Medicament
US10/404,345 US20030187044A1 (en) 1990-12-14 2003-04-01 Medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027197A GB9027197D0 (en) 1990-12-14 1990-12-14 Medicaments

Publications (1)

Publication Number Publication Date
GB9027197D0 true GB9027197D0 (en) 1991-02-06

Family

ID=10687033

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909027197A Pending GB9027197D0 (en) 1990-12-12 1990-12-14 Medicaments

Country Status (5)

Country Link
EP (1) EP0561896A1 (en)
JP (1) JPH06503338A (en)
AU (1) AU9069291A (en)
GB (1) GB9027197D0 (en)
WO (1) WO1992010186A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
EP0577025A3 (en) * 1992-07-01 1998-02-04 Hoechst Aktiengesellschaft Angiotensin-ii-receptorantagonist for the treatment and prophylaxis of coronary heart diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (en) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
EP0955294B1 (en) * 1989-06-14 2003-09-24 Smithkline Beecham Corporation Imidazolyl-alkenoic acid
US5140037A (en) * 1990-03-20 1992-08-18 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists

Also Published As

Publication number Publication date
JPH06503338A (en) 1994-04-14
EP0561896A1 (en) 1993-09-29
AU9069291A (en) 1992-07-08
WO1992010186A1 (en) 1992-06-25

Similar Documents

Publication Publication Date Title
GB9026998D0 (en) Medicaments
GB9012469D0 (en) Medicaments
CY2134B1 (en) Medicaments
AP9200403A0 (en) Medicaments
GB9027211D0 (en) Medicaments
GB9027210D0 (en) Medicaments
GB9115740D0 (en) Medicaments
GB9027200D0 (en) Medicaments
GB9027212D0 (en) Medicaments
GB9027208D0 (en) Medicaments
GB9027199D0 (en) Medicaments
GB9027198D0 (en) Medicaments
GB9027197D0 (en) Medicaments
GB9027201D0 (en) Medicaments
GB9027209D0 (en) Medicaments
GB9108348D0 (en) Medicaments
GB9104650D0 (en) Medicaments
GB9016951D0 (en) Medicaments
GB9022016D0 (en) Medicaments
GB9009067D0 (en) Medicaments
GB9016612D0 (en) Medicaments
GB9004015D0 (en) Medicaments
GB9011940D0 (en) Medicaments
GB9016950D0 (en) Medicaments
GB9010366D0 (en) Medicaments